Craft

Advanced
BIOTON

BIOTON

Stock Price

ZŁ3.4

2024-10-29

Market Capitalization

ZŁ288.9 M

2024-10-29

Revenue

ZŁ282.5 M

FY, 2025

BIOTON Summary

Company Summary

Overview
Bioton is a biotech company whose major therapeutic area is diabetes. It offers recombinant human insulin for injection form and oral hypoglycemic drugs, including glimepiride and metformin.
Type
Public
Status
Active
Founded
1989
HQ
Macierzysz, PL | view all locations
Website
https://bioton.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Table of Contents

Key People

  • Jeremy Launders

    Jeremy Launders, President of the Management Board

    • Dariusz Trzeciak, Vice-President of the Supervisory Board

      • Ramesh Rajentheran, Vice-President of the Supervisory Board

        LocationsView all

        1 location detected

        • Macierzysz, Mazowieckie HQ

          Poland

          Poznańska 12

        BIOTON Financials

        Summary Financials

        Revenue (FY, 2025)
        zł282.5M
        Gross profit (FY, 2025)
        zł128.4M
        Net income (FY, 2025)
        zł3.4M
        Cash (FY, 2025)
        zł8.3M
        EBIT (FY, 2025)
        zł13.9M
        Enterprise value
        $337.8M

        Competitors and Similar Companies

        Compare competitors

        Footer menu

        Product

        Solutions

        Resources

        Company

        © Craft.co 2026
        Share price data provided by IEX